The French Society of Internal Medicine’s Top-5 List of Recommendations: a National Web-Based Survey

• Published in: Journal of general internal medicine : JGIM 2019-08, Vol.34 (8), p.1475-1485
• Main Authors: Peiffer-Smadja, Nathan, Bauvois, Adeline, Chilles, Marie, Gramont, Baptiste, Maatoug, Redwan, Bismut, Marie, Thorey, Camille, Oziol, Eric, Hanslik, Thomas
• Format: Article
• Language: English
• Subjects: Anticoagulants; Correlation analysis; Dementia disorders; Diagnostic systems; Dyslipidemia; Geriatrics; Health care; Hypertension; Internal Medicine; Lyme disease; Medicine; Medicine & Public Health; Older people; Proton pump inhibitors; Risk factors; Risk perception; Thromboembolism; Vector-borne diseases
• ISSN: 0884-8734; 1525-1497
• DOI: 10.1007/s11606-019-05050-2

Background The international project “Choosing Wisely” aims to target unnecessary and potentially harmful examinations and treatments. Objective To define the French Internal Medicine Top-5 list. Design Based on a review of existing Top-5 lists and personal experience, a working group of the French National Society of Internal Medicine selected 27 diagnostic and therapeutic procedures. They were submitted through a national web-based survey to French internists who rated from 1 to 5 the perceived frequency, uselessness, and risk of each procedure. A composite score was calculated as the unweighted addition of the three scores. Participants Four hundred thirty internists answered the web-based survey (14% of all French internists including residents). All the French regions and status of the profession were represented. Key Results For the 27 submitted procedures, the mean score (± SD) was 3.25 (± 0.48) for frequency, 3.10 (± 0.43) for uselessness, and 2.63 (± 0.84) for risk. The Top-5 list obtained with the composite score was as follows: Do not prescribe long-term treatment with proton pump inhibitors without regular reevaluation of the indication Do not administer preventive treatments (e.g., for dyslipidemia, hypertension…) in elderly people with dementia when potential risks outweigh the benefits Do not administer hypnotic medications as first-line treatment for insomnia Do not treat with an anticoagulant for more than 3 months a patient with a first venous thromboembolism occurring in the setting of a major transient risk factor Do not screen for Lyme disease without an exposure history or related clinical examination findings We found that the composite score was strongly correlated to the risk score ( r s  = 0.88, p